{"id":"https://openalex.org/W2080644246","doi":"https://doi.org/10.1021/jm950761q","title":"Synthesis and Evaluation of N-(Phenylacetyl)trifluoromethanesulfonamides as Anticonvulsant Agents","display_name":"Synthesis and Evaluation of N-(Phenylacetyl)trifluoromethanesulfonamides as Anticonvulsant Agents","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2080644246","doi":"https://doi.org/10.1021/jm950761q","mag":"2080644246","pmid":"https://pubmed.ncbi.nlm.nih.gov/8691481"},"language":"en","primary_location":{"id":"doi:10.1021/jm950761q","doi":"https://doi.org/10.1021/jm950761q","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm950761q","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067088371","display_name":"Patrick T. Flaherty","orcid":"https://orcid.org/0000-0001-7925-3227","observed_orcids":["https://orcid.org/0000-0001-7925-3227"]},"institutions":[{"id":"https://openalex.org/I859038795","display_name":"Virginia Tech","ror":"https://ror.org/02smfhw86","country_code":"US","type":"education","lineage":["https://openalex.org/I859038795"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick T. Flaherty","raw_affiliation_strings":["Department of Chemistry and the Harvey W. Peters Research Center for the Study of Parkinson's Disease and Disorders of the Central Nervous System, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and the Harvey W. Peters Research Center for the Study of Parkinson's Disease and Disorders of the Central Nervous System, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212","institution_ids":["https://openalex.org/I859038795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055492279","display_name":"Thomas D. Greenwood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I859038795","display_name":"Virginia Tech","ror":"https://ror.org/02smfhw86","country_code":"US","type":"education","lineage":["https://openalex.org/I859038795"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas D. Greenwood","raw_affiliation_strings":["Department of Chemistry and the Harvey W. Peters Research Center for the Study of Parkinson's Disease and Disorders of the Central Nervous System, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and the Harvey W. Peters Research Center for the Study of Parkinson's Disease and Disorders of the Central Nervous System, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212","institution_ids":["https://openalex.org/I859038795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097828956","display_name":"Amy L. Manheim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I859038795","display_name":"Virginia Tech","ror":"https://ror.org/02smfhw86","country_code":"US","type":"education","lineage":["https://openalex.org/I859038795"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy L. Manheim","raw_affiliation_strings":["Department of Chemistry and the Harvey W. Peters Research Center for the Study of Parkinson's Disease and Disorders of the Central Nervous System, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and the Harvey W. Peters Research Center for the Study of Parkinson's Disease and Disorders of the Central Nervous System, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212","institution_ids":["https://openalex.org/I859038795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110334676","display_name":"James F. Wolfe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I859038795","display_name":"Virginia Tech","ror":"https://ror.org/02smfhw86","country_code":"US","type":"education","lineage":["https://openalex.org/I859038795"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James F. Wolfe","raw_affiliation_strings":["Department of Chemistry and the Harvey W. Peters Research Center for the Study of Parkinson's Disease and Disorders of the Central Nervous System, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and the Harvey W. Peters Research Center for the Study of Parkinson's Disease and Disorders of the Central Nervous System, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212","institution_ids":["https://openalex.org/I859038795"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I859038795"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.3074,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.61444393,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"39","issue":"7","first_page":"1509","last_page":"1513"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9300000071525574},{"id":"https://openalex.org/keywords/aryl-substituent-effects","display_name":"aryl substituent effects","score":0.8550000190734863},{"id":"https://openalex.org/keywords/picrotoxin-induced-seizures","display_name":"picrotoxin-induced seizures","score":0.9179999828338623},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8009999990463257},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.7149999737739563},{"id":"https://openalex.org/keywords/protective-index","display_name":"protective index","score":0.8159999847412109},{"id":"https://openalex.org/keywords/safety-margin","display_name":"safety margin","score":0.7620000243186951},{"id":"https://openalex.org/keywords/gaba-receptor-binding","display_name":"GABA receptor binding","score":0.7300000190734863},{"id":"https://openalex.org/keywords/flunitrazepam-binding","display_name":"flunitrazepam binding","score":0.871999979019165},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.8029999732971191},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.7310000061988831},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9810000061988831},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9890000224113464},{"id":"https://openalex.org/keywords/ethosuximide","display_name":"ethosuximide","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8845621347427368},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.8816803693771362},{"id":"https://openalex.org/C2779324764","wikidata":"https://www.wikidata.org/wiki/Q416602","display_name":"Picrotoxin","level":4,"score":0.790370762348175},{"id":"https://openalex.org/C2779619453","wikidata":"https://www.wikidata.org/wiki/Q421567","display_name":"Ethosuximide","level":4,"score":0.7798000574111938},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.6792339086532593},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6263344287872314},{"id":"https://openalex.org/C2780763569","wikidata":"https://www.wikidata.org/wiki/Q3639734","display_name":"Bicuculline","level":4,"score":0.5856974124908447},{"id":"https://openalex.org/C2778793413","wikidata":"https://www.wikidata.org/wiki/Q407241","display_name":"Phenobarbital","level":2,"score":0.5772736072540283},{"id":"https://openalex.org/C2777725853","wikidata":"https://www.wikidata.org/wiki/Q194406","display_name":"Strychnine","level":2,"score":0.5235666632652283},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5031303763389587},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4851608872413635},{"id":"https://openalex.org/C2777992146","wikidata":"https://www.wikidata.org/wiki/Q420383","display_name":"Primidone","level":4,"score":0.47642311453819275},{"id":"https://openalex.org/C201399114","wikidata":"https://www.wikidata.org/wiki/Q898401","display_name":"Lipophilicity","level":2,"score":0.45811572670936584},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.3632400631904602},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.33955252170562744},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.2702714204788208},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18444538116455078},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1163938045501709},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.10188111662864685},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.08160194754600525},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008698","descriptor_name":"Mesylates","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D008698","descriptor_name":"Mesylates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008698","descriptor_name":"Mesylates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008698","descriptor_name":"Mesylates","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D008698","descriptor_name":"Mesylates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009251","descriptor_name":"NADPH-Ferrihemoprotein Reductase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009929","descriptor_name":"Organ Size","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010090","descriptor_name":"Oxidoreductases, O-Demethylating","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm950761q","doi":"https://doi.org/10.1021/jm950761q","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm950761q","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:8691481","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8691481","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5043096689","display_name":null,"funder_award_id":"NS10197","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1975423291","https://openalex.org/W1980918385","https://openalex.org/W1982891404","https://openalex.org/W1982904143","https://openalex.org/W1995137974","https://openalex.org/W2027861706","https://openalex.org/W2031168609","https://openalex.org/W2055585923","https://openalex.org/W2065074033","https://openalex.org/W2073574286","https://openalex.org/W2117614741","https://openalex.org/W2143496876","https://openalex.org/W2323471917","https://openalex.org/W2420350978","https://openalex.org/W4205458182"],"related_works":["https://openalex.org/W2136835925","https://openalex.org/W2049653098","https://openalex.org/W3082716267","https://openalex.org/W2080284580","https://openalex.org/W2089723968","https://openalex.org/W2469971359","https://openalex.org/W2325341493","https://openalex.org/W2949808711","https://openalex.org/W2003958520","https://openalex.org/W1989526036"],"abstract_inverted_index":{"A":[0],"series":[1],"of":[2,97],"N-(phenylacetyl)trifluoromethanesulfonamides":[3],"(3a-g)":[4],"was":[5,46,109],"prepared":[6],"according":[7],"to":[8,14,86],"the":[9,72,101],"Topliss":[10],"scheme":[11],"in":[12,69,89],"order":[13],"determine":[15],"if":[16],"aryl":[17],"substituents":[18],"would":[19],"influence":[20],"anticonvulsant":[21],"activity.":[22],"In":[23,118],"initial":[24],"(phase":[25,30],"I)":[26],"screening":[27],"and":[28,41,64,78,92,135],"quantitative":[29],"II)":[31],"evaluation,":[32],"all":[33,90],"seven":[34],"compounds":[35],"exhibited":[36,82],"significant":[37],"activity":[38],"against":[39,111],"MES-":[40],"scMet-induced":[42],"seizures.":[43],"N-(Phenylacetyl)trifluoromethanesulfonamide":[44],"(3a)":[45],"then":[47],"advanced":[48],"through":[49],"five":[50],"additional":[51],"testing":[52],"phases":[53],"(phases":[54],"III-VII).":[55],"Compound":[56,103],"3a":[57,81,104,125],"displayed":[58],"good":[59],"oral":[60],"bioavailability,":[61],"low":[62],"toxicity,":[63],"a":[65,83,93,141],"larger":[66],"protective":[67],"index":[68],"mice":[70],"than":[71,100],"prototype":[73],"drugs,":[74],"phenytoin,":[75],"phenobarbital,":[76],"valproate,":[77],"ethosuximide.":[79],"Additionally,":[80],"longer":[84],"time":[85],"peak":[87],"effect":[88],"tests":[91],"greater":[94],"24-h":[95],"margin":[96],"safety":[98],"(HD(50)/ED(50))":[99],"prototypes.":[102],"blocked":[105],"picrotoxin-induced":[106],"seizures":[107,112],"but":[108],"ineffective":[110],"induced":[113],"by":[114],"bicuculline":[115],"or":[116,132],"strychnine.":[117],"vitro":[119],"receptor":[120],"binding":[121],"studies":[122],"revealed":[123],"that":[124],"did":[126,137],"not":[127,138],"displace":[128],"[(3)H]-labeled":[129,133],"gamma-aminobutyric":[130],"acid":[131],"flunitrazepam,":[134],"tolerance":[136],"develop":[139],"during":[140],"5-day":[142],"chronic":[143],"administration.":[144]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}